BAM
CRL icon

Burgundy Asset Management’s Charles River Laboratories CRL Stock Holding History

Burgundy Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$45.5M Sell
278,329
-1,841
-0.7% -$292K 0.43% 73
2025
Q2 		$42.5M Buy
280,170
+277,450
+10,200% +$37M 0.41% 73
2025
Q1 		$409K Buy
2,720
+1,416
+109% +$237K ﹤0.01% 104
2024
Q4 		$241K Hold
1,304
– – ﹤0.01% 102
2024
Q3 		$257K Buy
1,304
+231
+22% +$48K ﹤0.01% 104
2024
Q2 		$222K Hold
1,073
– – ﹤0.01% 103
2024
Q1 		$291K Hold
1,073
– – ﹤0.01% 100
2023
Q4 		$254K Buy
+1,073
New +$211K ﹤0.01% 103

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Burgundy Asset Management's CRL Position: Q3 2025 in Review

Burgundy Asset Management reduced its Charles River Laboratories (CRL) stake by 0.66% in Q3 2025, selling an estimated $292K and leaving 278,329 shares worth $45.5M. The position accounts for 0.43% of the portfolio, ranked #73.

Burgundy Asset Management first reported a position in CRL in Q4 2023 and has held it in 8 quarters since. 556 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

  • Burgundy Asset Management held 278,329 shares of Charles River Laboratories worth $45.5M as of Q3 2025.
  • Burgundy Asset Management sold 1,841 Charles River Laboratories shares in Q3 2025, an estimated $292K.
  • Charles River Laboratories made up 0.43% of Burgundy Asset Management's portfolio in Q3 2025, its #73 holding.
  • Burgundy Asset Management first reported a position in Charles River Laboratories in Q4 2023 and has held it in 8 quarters since.
  • 556 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Burgundy Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.